← Back to Search

Supportive Care for High Cholesterol (ALLTOP Trial)

N/A
Waitlist Available
Led By Robert D Fishberg, MD
Research Sponsored by Atlantic Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Family history of CAD in first degree relative
Personal history of CAD
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months from enrollment in study
Awards & highlights
No Placebo-Only Group

Summary

"This trial aims to improve treatment for patients with high cholesterol levels by creating a lipid workgroup at Atlantic Medical Group. The goal is to enhance lipid disorder treatment by improving access to resources at both primary care

Who is the study for?
This trial is for individuals with high cholesterol or related lipid disorders. It's aimed at those who could benefit from improved treatment access both at their primary care and specialty levels. The goal is to identify high-risk patients using electronic health records and work closely with their primary doctors for better management.
What is being tested?
The program isn't testing a specific drug, but rather a new approach to managing high cholesterol by optimizing the use of resources in medical practices. This includes following guidelines more closely and possibly integrating new strategies into patient care.
What are the potential side effects?
Since this trial focuses on supportive care rather than medication, side effects are not the main concern here. However, any changes in treatment plans may come with risks or discomforts typically associated with adjustments in healthcare management.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
A close family member has had coronary artery disease.
Select...
I have a history of coronary artery disease.
Select...
I had a heart attack and am not on the best cholesterol medicine.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months from enrollment in study
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months from enrollment in study for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Proportion of patients with LDL-C maintenance<100
Secondary study objectives
Proportion of patients with LDL-C reaching <55
Proportion of patients with LDL-C reaching <75

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: LDL-CExperimental Treatment1 Intervention
Most recent LDL-C result

Find a Location

Who is running the clinical trial?

Atlantic Health SystemLead Sponsor
54 Previous Clinical Trials
7,287 Total Patients Enrolled
Regeneron PharmaceuticalsIndustry Sponsor
671 Previous Clinical Trials
385,593 Total Patients Enrolled
Robert D Fishberg, MDPrincipal InvestigatorAtlantic Health System
~167 spots leftby May 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top